Xue Wu - Autobio Diagnostics Deputy Director

603658 Stock   40.09  0.11  0.27%   

Director

Xue Wu is Deputy Director of Autobio Diagnostics Co
Age 58
Address No. 199, Jingkai 15th Street, Zhengzhou, China, 450016
Phone86 40 0056 9995
Webhttps://www.autobio.com.cn

Autobio Diagnostics Management Efficiency

The company has return on total asset (ROA) of 0.0705 % which means that it generated a profit of $0.0705 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1518 %, meaning that it generated $0.1518 on every $100 dollars invested by stockholders. Autobio Diagnostics' management efficiency ratios could be used to measure how well Autobio Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. At present, Autobio Diagnostics' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 657.2 M, whereas Intangible Assets are forecasted to decline to about 141.4 M.

Similar Executives

Showing other executives

DIRECTOR Age

Zhihong JiChina Construction Bank
56
Xuguang ZhangAgricultural Bank of
60
Cunxing DuBank of China
N/A
Fuxiao ShenPetroChina Co Ltd
55
Pizheng LiChina Mobile Limited
59
Wei WangBank of China
61
Wanfu ZhouBank of Communications
60
Fangzheng JiaoPetroChina Co Ltd
61
Ronghua LiChina Mobile Limited
59
Hong YaoPostal Savings Bank
59
Xuewen ZhangPostal Savings Bank
62
Li LinAgricultural Bank of
57
Zhang ShouchuanBank of China
N/A
Guoyu ZhengIndustrial and Commercial
57
Limin WangChina Mobile Limited
56
Jiuyong YinBank of Communications
58
Lixin RenPetroChina Co Ltd
57
Jingzhen LinBank of China
60
Fanggen LiuChina Construction Bank
N/A
Autobio Diagnostics Co (603658) is traded on Shanghai Stock Exchange in China and employs 5,539 people. Autobio Diagnostics is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Autobio Diagnostics Leadership Team

Elected by the shareholders, the Autobio Diagnostics' board of directors comprises two types of representatives: Autobio Diagnostics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Autobio. The board's role is to monitor Autobio Diagnostics' management team and ensure that shareholders' interests are well served. Autobio Diagnostics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Autobio Diagnostics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Guang Fu, Executive Director
Rui Fang, Deputy Directors
Chao Wang, Deputy Mang
Chao Feng, Financial GM
Qin Yun, Deputy Mang
Gui Li, Deputy Mang
Liu Cong, Deputy Mang
Wei Liu, Supervisor Center
Zeng Yang, GM Director
Xue Wu, Deputy Director
Bin Li, Deputy Center

Autobio Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Autobio Diagnostics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Autobio Stock

Autobio Diagnostics financial ratios help investors to determine whether Autobio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Autobio with respect to the benefits of owning Autobio Diagnostics security.